GM23163
LCL from B-Lymphocyte
Description:
NEUROFIBROMATOSIS, TYPE II; NF2
NEUROFIBROMIN 2; NF2
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Hereditary Cancers |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Family History
|
N
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
NF2 |
| Chromosomal Location |
22q12.2 |
| Allelic Variant 1 |
; NEUROFIBROMATOSIS, TYPE 2 |
| Identified Mutation |
NF2 GENE DELETION |
| |
| Gene |
NF2 |
| Chromosomal Location |
22q12.2 |
| Allelic Variant 2 |
; NEUROFIBROMATOSIS, TYPE 2 |
| Identified Mutation |
1026_1027delAG |
| Remarks |
Clinically affected; unilateral moderate hearing loss and unilateral vestibular schwannoma; asymptomatic spinal tumors and schwannomas (right thumb, left wrist, right palm); founder mosaic for NF2: analysis of donor subject's tumor tissue showed that one allele has a total NF2 gene deletion and a second allele has a 2 bp deletion at nucleotide 1026 (c.1026_1027delAG) |
| Gene Cards |
NF2 |
| Gene Ontology |
GO:0005198 structural molecule activity |
|
GO:0005856 cytoskeleton |
|
GO:0005886 plasma membrane |
|
GO:0007605 perception of sound |
|
GO:0008092 cytoskeletal protein binding |
|
GO:0008285 negative regulation of cell proliferation |
|
GO:0045786 negative regulation of cell cycle |
| NCBI Gene |
Gene ID:4771 |
| NCBI GTR |
101000 NEUROFIBROMATOSIS, TYPE II; NF2 |
|
607379 NEUROFIBROMIN 2; NF2 |
| OMIM |
101000 NEUROFIBROMATOSIS, TYPE II; NF2 |
|
607379 NEUROFIBROMIN 2; NF2 |
| Omim Description |
ACOUSTIC NEURINOMA, BILATERAL; ACNNEUROFIBROMIN 2, INCLUDED |
| |
ACOUSTIC SCHWANNOMAS, BILATERAL |
| |
BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF |
| |
MERLIN, INCLUDED |
| |
NEUROFIBROMATOSIS, CENTRAL TYPE |
| |
NEUROFIBROMATOSIS, TYPE II; NF2 |
| |
SCHWANNOMIN, INCLUDED; SCH, INCLUDED |
| Split Ratio |
1:4 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|